Back

Results from real-world evidence and randomized controlled clinical studies with the combination of amlodipine and valsartan

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Treatment of hypertension Treatment of hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Patrick Brunel

Basel (Switzerland)

10 More presentations in this session

Presentation thumbnail
A novel approach to perform renal sympathetic denervation in moderate to severe chronic kidney disease using carbon dioxide angiography
Doctor M. Hameed (Birmingham, GB)
Abstract
Presentation thumbnail
Statins and perindopril\amlodipine efficacy in hypertensive patients with hypercholesterolemia
Professor G. Radchenko (Kiev, UA)
Abstract Slides
Presentation thumbnail
Poor control of blood pressure is associated with increased risk of cardiovascular events in hypertensive patients with atherosclerotic vascular diseases, especially in the elderly
Associate Professor W. Chang (Taipei, TW)
Abstract Slides
Presentation thumbnail
Factors that exacerbate resistance to the antihypertensive treatment in hypertensive patients with diabetes
Professor Y. Dohi (Nagoya, JP)
Abstract
Presentation thumbnail
Is ARB/CCB combination superior to ARB/HCTZ combination in day-by-day blood pressure variability reduction? a prospective randomized trial
Professor H. Kai (Miyama, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Treatment of hypertension

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources